Trial Profile
Randomised, Open-label, Parallel-group Study of Therapeutic Effect of Leukotriene Modulator Montelukast Alone or Combined With Inhaled Corticosteroid on Cough Variant Asthma.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Budesonide/formoterol
- Indications Asthma
- Focus Therapeutic Use
- 02 Dec 2013 Planned end date changed from 1 Apr 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 16 Nov 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 08 Feb 2012 Planned End Date changed from 1 Dec 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.